Health-related quality of life and cost of ambulatory care in osteoporosis: how may such outcome measures be valuable information to health decision makers and payers?
Ethgen, Olivier; Tellier, V.; Sedrine, W. B.et al.
Health-related quality of life and cost of ambulatory care in osteoporosis how may such outcome measures be valuable information to health decision makers and payers.pdf
Ambulatory Care/economics/psychology; osteoporosis; health-related quality of life; Cross-Sectional Studies; cost; Female; ambulatory care; Health Care Costs/statistics & numerical data; health service research; Health Status; Humans; Male; Middle Aged; Multivariate Analysis; Osteoporosis/economics/psychology/therapy; Outcome Assessment (Health Care)/economics; Quality of Life/psychology
Abstract :
[en] The objective was to quantify the outcome of osteoporosis (OP) in terms of health-related quality of life (HR-QOL) and cost of ambulatory care and to look at the association between these two outcomes variables. A cross-sectional health survey of 4800 Belgian individuals over the age of 45 years was used. Individuals having reported OP were retrieved and for each of them, at least two matched individuals for age, sex, residency location, and health insurance status were identified. All individuals were assessed with the SF-36. The two major health insurance providers furnished cost value for ambulatory care. HR-QOL and cost data were compared between the OP group and control group. Beta-coefficients from linear regression were calculated to give information on the relative importance of the association between each SF-36 dimensions and cost of ambulatory care. Of 4796 individuals appropriately surveyed, 221 (4.8%) reported OP. The control group included 651 individuals. The OP group experienced impaired HR-QOL compared to their matched counterparts, all the difference in mean or median SF-36 scores being significant at the level of P < 0.001. Osteoporotic respondents averaged 816 in cost of ambulatory care whereas controls averaged 579 (P < 0.001). When looking at detailed comparisons between categories of cost, costs in the OP group far exceeded those in the control group, all the differences being significant at the level of P < 0.001 except for home health nurse (P = 0.012). In the OP group, vitality dimensions played the most important role in the determination of cost (beta = -0.28, P < 0.001), followed by physical functioning (beta = -0.26, P < 0.01), general health, and social functioning (beta = -0.23, P < 0.01). This study evidences the burden of OP in terms of HR-QOL and cost of ambulatory care. Exploring the association between HR-QOL and cost show that mental dimension such as vitality can play an important role in the determination of cost. Conclusively, they should not be neglected in future management of OP.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Ethgen, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique : aspects spécifiques
Tellier, V.
Sedrine, W. B.
De Maeseneer, J.
Gosset, Christiane ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique : aspects généraux
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie et santé publique
Language :
English
Title :
Health-related quality of life and cost of ambulatory care in osteoporosis: how may such outcome measures be valuable information to health decision makers and payers?
Publication date :
June 2003
Journal title :
BONE
ISSN :
8756-3282
eISSN :
1873-2763
Publisher :
Elsevier Science Inc, New York, United States - New York
Gillespy T., Gillespy M.P. Osteoporosis. Radiol Clin North Am. 29:1991;77-84.
Kanis J.A., Pitt F.A. Epidemiology of osteoporosis. Bone. 13:1992;S7-S15.
Chrischilles E.A., Butler D., Davis C.S., Wallace R.B. A model of lifetime osteoporosis impact. Arch Intern Med. 151:1991;2026-2032.
Riggs B.L., Melton L.J. The worldwide problem of osteoporosis insights afforded by epidemiology . Bone. 17:(Suppl. 5):1995;505S-511S.
Chrischilles E.A., Shireman T., Wallace R.B. Costs and health effects of osteoporotic fractures. Bone. 15:1994;377-386.
Melton L.J. Hip fractures a worldwide problem today and tomorrow . Bone. 14:(Suppl. 1):1993;S1-S8.
Gillet P., Reginster J.-Y. Increased number of hip fractures. Lancet. 353:1999;2160-2161.
Johnell O. The socioeconomic burden of fractures today and in the 21st century . Am J Med. 103:(Suppl. 2A):1997;20S-26S.
Eisenberg J.M. Why a journal of pharmacoeconomics? Pharmacoeconomics. 1:1992;2-4.
Reginster J.-Y., Gillet P., Ben Sedrine W., et al. Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics. 15:1999;507-514.
Randell A., Sambrook P.N., Nguyen T.V., et al. Direct clinical and welfare costs of osteoporotic fractures in elderly men and women. Osteoporosis Int. 5:1995;427-432.
Reginster J.-Y. Cost effectiveness of treatments in osteoporosis [Editorial]. J Rheumatol. 23:1996;1312-1313.
Rosner A.J., Grima D.T., Torrance G.W., et al. Cost-effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis. Pharmacoeconomics. 4:1998;559-573.
Cook D.J., Guyatt G.H., Adachi J.D., et al. Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum. 36:1993;750-756.
Silverman S.L., Cranney A. Quality of life measurement in osteoporosis. J Rheumatol. 24:1997;1218-1221.
Health-related quality of life in osteoporosis clinical trials. Calcif Tissue Int. 53:1993;75-77.
Helmes E., Hodsman A., Lazowski D., et al. A questionnaire to evaluate disability in osteoporotic patients with vertebral compression fractures. J Gerontol Med Sci. 50A:1995;M91-M98.
Lips P., Cooper C., Agnusdei D., et al. Quality of life in patients with vertebral fractures validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis . Osteoporos Int. 10:1999;150-160.
Lydick E., Zimmerman S.I., Yawn B., et al. Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res. 12:1997;456-463.
Measuring quality of life in women with osteoporosis. Osteoporosis Int. 7:1997;478-487.
Randell A.G., Bahlerao N., Nguyen T.V., et al. Quality of life in osteoporosis reliability, consistency, and validity of the Osteoporosis Assessment Questionnaire . J Rheumatol. 25:1998;1171-1179.
Lamberts H., Wood M. ICPC international classification of primary care. 1987;Oxford Univ. Press, WONCA, London.
Ware J.E., Sherbourne C.D. The MOS 36-Item Short-Form Health Status Survey (SF-36):1. Conceptual framework and item selection. Med Care. 30:1992;473-483.
Ware J.E. The SF-36 Health Survey. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed: 1996;337-345 Lippincott-Raven Publishers, Philadelphia, PA.
McHorney C.A., Ware J.E., Lu J.F., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36) III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups . Med Care. 32:1994;40-66.
Ravazi D., Gandek B. Testing Dutch and French translations of the SF-36 Health Survey among Belgian angina patients. J Clin Epidemiol. 51:1998;975-981.
Leplège A., Ecosse E., Verdier A., Perneger T.V. The French SF-36 Health Survey translation, cultural adaptation and preliminary psychometric evaluation . J Clin Epidemiol. 51:1998;1013-1023.
Aaronson N.K., Muller M., Cohen P.D., et al. Translation, validation, and norming of the Ducth language version of the SF-36 Health Survey in community disease populations. J Clin Epidemiol. 51:1998;1055-1068.
Hirsch R.P., Riegelman R. Statistical operations. Analysis of health research data. 1996;Blackwell Science, Cambridge, MA.
WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. World Health Organization, Geneva, 1994.
Phillips S., Fox N., Jacobs J., Wright W.E. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone. 9:1988;271-279.
Burke T.A., Zabinski R.A., Pettitt D., et al. A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis. Pharmacoeconomics. 19:(Suppl. 1):2001;33-47.
MacDonald T.M., Morant S.V., Robinson G.C., et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure; a cohort study. BMJ. 315:1997;1333-1337.
Maconi G., Porro G.B. Multiple ulcerative oesophagetis caused by alendronate. Am J Gastroenterol. 90:1995;1889-1890.
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 343:2000;1902-1909.
Israel E., Banerjee T.R., Fitzmaurice G.M., et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 345:2001;941-947.
De Boer A.G.E.M., Wijtker W., De Haes H.C.J.M. Predictors of health care utilization in the chronically ill a review of the literature . Health Policy. 42:1997;101-105.
Ethgen O., Kahler K.H., Kong S.X., Reginster J.-Y., Wolfe F. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis a longitudinal analysis . J Rheumatol. 29:2002;1147-1155.
Yelin E., Wanke L.A. An assessment of the annual and long-term direct costs of rheumatoid arthritis. The impact of poor function and functional decline. Arthritis Rheum. 42:1999;1209-1218.
Tessler R., Mechanic D., Dimond M. The effect of psychological distress on physician utilization a prospective study . J Health Soc Behav. 17:1976;353-364.
Zimmerman S.I., Fox K.M., Magaziner J. Psychosocial aspects of osteoporosis. Phys Med Rehabil Clin N Am. 6:1993;441-453.